Introducing a cost-effective vibration therapy solution integrated into immobilization casts to alleviate neuropathic pain. This technology allows self-administered pain relief through a magnetic actuator system, enhancing patient comfort during recovery.
This innovative solution integrates vibration therapy capabilities directly into immobilization casts, providing a self-administered method for managing neuropathic pain associated with casts used in orthopedic treatments. The system is designed to be safe and cost-effective, utilizing a magnetic actuator embedded within the cast, which can be activated by an external, reusable handheld device. This approach offers significant benefits, including improved patient comfort, reduced risk of tissue damage from manual manipulation, and enhanced treatment outcomes.
The technology is currently at TRL 4, having been validated in laboratory settings. Future steps include refining the prototype for easy cast integration, conducting a pilot study to assess efficacy and safety, and preparing for larger clinical trials. The development team is comprised of experts in orthopedic technology and clinical engineering, with access to state-of-the-art facilities for further testing and refinement.
The University of Pittsburgh is a large, comprehensive public research university anchored in an urban innovation corridor with a strong translational focus. Integration with UPMC, a leading academic medical center, enables clinical studies, access to broad patient populations, and co-located clinical–engineering labs that shorten paths from discovery to deployment. A nearby research and technology district, extensive core facilities, and an engineering co-op program give companies entry points for prototyping and talent pipelines. Research is supported by competitive federal funding from agencies such as NIH, NSF, DoD, and DOE. A dedicated technology transfer office provides IP strategy, licensing, startup support, and contracting for industry partners.